AIM ImmunoTech (AIM) Capital Leases (2010 - 2014)
AIM ImmunoTech (AIM) reported Capital Leases of $3,000 for Q3 2014, down 90.3% from $31,000 a year earlier and down 57.1% from the prior quarter.
Powered by 
Analysis
AIM ImmunoTech (AIM) Capital Leases (2010 - 2014) Analysis & Trends
At the end of FY2013, AIM ImmunoTech posted Capital Leases of $23,000, down 58.2% from FY2012.
- Capital Leases has a three-year compound annual growth rate of -37.9% (FY2010 to FY2013).
- By year, Capital Leases came in at $55,000 in FY2012 (-44.4%), $99,000 in FY2011 (+3.1%) and $96,000 in FY2010.
- The Q3 2014 figure ranks as the lowest quarterly Capital Leases in data going back to Q4 2010.
- Year over year, Capital Leases has now declined in each of the last ten quarters, with an average decline of 61.2% over the last eight quarters.
- The high point for year-over-year Capital Leases in five years was Q4 2011 (growth of 3.1%); the low point was Q3 2014 (a decline of 90.3%).
- Per Business Quant data, the three quarters before Q3 2014 came in at $7,000 (Q2 2014), $15,000 (Q1 2014) and $23,000 (Q4 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2014 | 3,000.00 |
| Jun 30, 2014 | 7,000.00 |
| Mar 31, 2014 | 15,000.00 |
| Dec 31, 2013 | 23,000.00 |
| Sep 30, 2013 | 31,000.00 |
| Jun 30, 2013 | 37,000.00 |
| Mar 31, 2013 | 45,000.00 |
| Dec 31, 2012 | 55,000.00 |
| Sep 30, 2012 | 64,000.00 |
| Jun 30, 2012 | 73,000.00 |
| Mar 31, 2012 | 86,000.00 |
| Dec 31, 2011 | 99,000.00 |
| Sep 30, 2011 | 112,000.00 |
| Jun 30, 2011 | 123,000.00 |
| Dec 31, 2010 | 96,000.00 |
API Access
AIM ImmunoTech Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();